Telescope Innovations to Attend Cantech Investment Conference in Toronto
News related to:Telescope Innovations Corp · 2 min read
Telescope Innovations Corp., a leading developer of Physical AI systems, including Self-Driving Laboratories (SDLs), will have a presence at the 2026 Cantech Investment Conference in Toronto. The event, organized by Cantech Letter, is billed as Canada's foremost technology investment conference and will take place on October 8, 2026, from 8:00 a.m. to 5:00 p.m. at the Arcadian Loft, 401 Bay Street.
Members of the company’s leadership team will attend the conference, including the CEO, Henry Dubina. Management will hold meetings with investors, analysts, and industry participants to discuss the company’s Self-Driving Lab (SDL) deployments, its DirectInject-LC™ technology, and its growth strategy.
Telescope Innovations Corp. is at the forefront of the Physical AI revolution in the chemical and pharmaceutical industries. The company’s Self-Driving Labs are now installed or contracted at major global pharmaceutical organizations in Asia, North America, and Europe. These labs are running at Pfizer, in Seoul, and at a major pharmaceutical company in Europe, marking significant milestones for the company.
In June 2026, Telescope signed an agreement with a major global pharmaceutical company in Europe for a Self-Driving Lab dedicated to crystallization, one of the most critical and time-intensive stages of drug development. In February 2026, the company installed a second Self-Driving Lab at Pfizer under its multi-year agreement, signaling a transition from collaborative research to broader deployment in pharmaceutical development.
The company also installed its first Self-Driving Lab at the Korean Pharmaceutical and Biopharma Manufacturers Association (KPBMA) in December 2025, marking the first SDL in Korea for pharmaceutical research, development, and education. This system is also the first SDL in Asia, expanding Telescope’s reach and influence in the region.
Telescope’s technology is also being recognized on a broader scale. In September 2026, the company’s Chief Technology Officer, Prof. Jason Hein, was invited to the kickoff of the US National Science Foundation’s US$380 million initiative to build a national network of AI-enabled automated laboratories. Additionally, in June 2026, Prof. Hein received the 2026 SCI Canada LeSueur Memorial Award.
The company has also strengthened its board with the addition of Dr. E. Neil Lewis, a chemist, spectroscopy pioneer, and founder of three technology companies. Furthermore, Telescope and AGI SDA launched a collaboration to develop a next-generation chemical reactor for automated laboratories in March 2026.
Telescope’s Self-Driving Labs are Physical AI systems that combine robotics, real-time process analytics, and artificial intelligence to plan, run, and analyze chemistry experiments autonomously. These labs execute each experiment, measure the outcome as it happens, and use AI to decide the next experiment, running around the clock with minimal human intervention. This technology compresses development timelines, reduces material and labor costs, and produces high-quality, machine-readable data that strengthens each subsequent program.
Governments and industry are investing heavily in the field, including the US National Science Foundation’s US$380 million Programmable Cloud Laboratories initiative. Telescope is positioned to capitalize on this growth, with its leadership in the development of autonomous chemistry platforms for commercial drug development.
The Cantech Investment Conference is an opportunity for Telescope to showcase its advancements and engage with key stakeholders. The company’s presence at the conference underscores its commitment to innovation and its position as a leader in the Physical AI space.